About PrediSurge
PrediSurge is a company based in Saint-etienne (France) founded in 2017 by Stephane Avril, Alban Molle, and David Perrin. PrediSurge has raised $8.51 million across 4 funding rounds from investors including European Union, Liftt and Ui Investissement. PrediSurge offers products and services including PlanOp™ Aortic, PlanOp™ iView Pro, PlanOp™ iView Colour, and PlanOp™ Virtual Lab. PrediSurge operates in a competitive market with competitors including Qianglian Zhichuang, Artrya, Topspin Medical, Saigeware Technologies and Capical, among others.
- Headquarter Saint-etienne, France
- Founders Stephane Avril, Alban Molle, David Perrin
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8.51 M (USD)
in 4 rounds
-
Latest Funding Round
$6.83 M (USD), Series A
Oct 16, 2023
-
Investors
European Union
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PrediSurge
PrediSurge offers a comprehensive portfolio of products and services, including PlanOp™ Aortic, PlanOp™ iView Pro, PlanOp™ iView Colour, and PlanOp™ Virtual Lab.
Software for simulating aortic interventions to enhance planning.
Tool for visualizing cardiovascular data through simulations.
Platform for color-based analysis in endovascular procedures.
Environment for testing and adjusting medical device designs.
Funding Insights of PrediSurge
PrediSurge has successfully raised a total of $8.51M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $6.83 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in PrediSurge
PrediSurge has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Liftt and Ui Investissement.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for PrediSurge
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PrediSurge
Investment portfolio details for PrediSurge
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PrediSurge
Detailed financials for PrediSurge
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Predisurge Comparisons
Peer comparison for PrediSurge
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PrediSurge
PrediSurge operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Qianglian Zhichuang, Artrya, Topspin Medical, Saigeware Technologies and Capical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-driven solutions for cerebrovascular disease diagnosis and treatment are developed.
|
|
| Locked | Locked | Locked |
AI-based cardiovascular analysis tools are provided to healthcare providers.
|
|
| Locked | Locked | Locked |
Develops intravascular MRI catheters for coronary artery applications.
|
|
| Locked | Locked | Locked |
AI-based decision support tool for cardiac and pulmonary practices
|
|
| Locked | Locked | Locked |
ECG devices utilizing capacitive electrodes are developed by Capical.
|
Detailed competitors of PrediSurge
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Predisurge
Complete news archive for PrediSurge
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PrediSurge
PrediSurge was founded in 2017 and raised its 1st funding round 3 years after it was founded.
PrediSurge is headquartered in Saint-etienne, France. It is registered at Saint-etienne, Loire, France.
Alban Molle is the current CEO of PrediSurge. They have also founded this company.
PrediSurge is a funded company, having raised a total of $8.51M across 4 funding rounds to date.
Predisurge provides decision-making tools for cardiologists. It predicts organ deformation and device behavior within patient anatomy. Provides secured intervention by case rehearsal with 3D interactive visualization simulation analysis. The company also provide a secured online platform connecting physicians firms for enhanced collaboration to design medical devices.
PrediSurge's top competitors include Saigeware Technologies, Artrya and x-cardiac.
PrediSurge offers PlanOp™ Aortic, PlanOp™ iView Pro, PlanOp™ iView Colour, and PlanOp™ Virtual Lab.
PrediSurge has 4 investors. Key investors include European Union, Liftt, Ui Investissement, and EIC Fund.